Brachytherapy Clinical Trials

9 recruiting

Brachytherapy Trials at a Glance

13 actively recruiting trials for brachytherapy are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Zamość, Salt Lake City, and Beijing. Lead sponsors running brachytherapy studies include Affidea Nu-med Center of Oncological DIagnostics and Therapy, Peking University Third Hospital, and Clarity Pharmaceuticals Ltd.

Browse brachytherapy trials by phase

Treatments under study

About Brachytherapy Clinical Trials

Looking for clinical trials for Brachytherapy? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Brachytherapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Brachytherapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 3

64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

Prostate CancerCryotherapyProstate Cancer Recurrent+3 more
Clarity Pharmaceuticals Ltd220 enrolled28 locationsNCT06970847
Recruiting
Phase 2Phase 3

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

Prostate Cancer (Adenocarcinoma)Stereotactic Body Radiation Therapy (SBRT)Localized Prostate Cancer+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy1,200 enrolled1 locationNCT07426055
Recruiting
Phase 2

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

Cervical CancerEndometrial CancerVaginal Cancer+4 more
University of Utah68 enrolled1 locationNCT05979610
Recruiting
Phase 2Phase 3

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

Prostate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy1,600 enrolled1 locationNCT07426094
Recruiting

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Prostate Cancer RecurrentProstate Cancer (Diagnosis)Prostate Cancer Patients Treated by Radiotherapy+1 more
University of Erlangen-Nürnberg Medical School200 enrolled3 locationsNCT07131956
Recruiting
Not Applicable

Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.

Radiotherapy Side EffectProstate CancerRadiotherapy+3 more
CHU de Quebec-Universite Laval205 enrolled1 locationNCT05786742
Recruiting

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Prostate CancerRadiotherapy; ComplicationsBrachytherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra20 enrolled1 locationNCT06982469
Recruiting
Phase 2

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma

Sarcoma,Soft TissueBrachytherapyPoly(ADP-ribose) Polymerase Inhibitors
Fujun Zhang32 enrolled1 locationNCT05894018
Recruiting

In Vivo Treatment Verification of Brachytherapy

Brachytherapy
Maastricht Radiation Oncology100 enrolled1 locationNCT06240559
Recruiting
Not Applicable

Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy

Rectal CancerComorbidities and Coexisting ConditionsBrachytherapy+1 more
Sir Mortimer B. Davis - Jewish General Hospital45 enrolled1 locationNCT04336202
Recruiting

I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After Radiotherapy

Non-small Cell Lung CancerBrachytherapy
Peking University Third Hospital30 enrolled1 locationNCT04071418
Recruiting
Not Applicable

3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors

Thoracic CancerRadioactive Iodine-125 Brachytherapy3D Printing Coplanar Template+1 more
Peking University Third Hospital30 enrolled1 locationNCT05351268
Recruiting

Retrospective Study of Brachytherapy

Ovarian NeoplasmsUterine Cervical NeoplasmsVaginal Cancer+4 more
Zhejiang Cancer Hospital300 enrolled1 locationNCT05242861